METASTATIC MALIGNANT NEOPLASM
Clinical trials for METASTATIC MALIGNANT NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MALIGNANT NEOPLASM trials appear
Sign up with your email to follow new studies for METASTATIC MALIGNANT NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Genetic blueprint vs. standard care: which fights spreading cancer better?
Disease control OngoingThis study is testing whether choosing cancer drugs based on the unique genetic changes found in a patient's tumor is more effective at controlling the disease than standard treatment. It involves over 1,300 people with metastatic cancer, meaning cancer that has spread. Patients …
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Brain cancer trial tests precision radiation to protect memory
Disease control OngoingThis study compares two types of radiation therapy for patients with 4 to 15 brain metastases from cancers other than melanoma. One method targets tumors precisely with a single high dose, while the other treats the entire brain with lower doses over two weeks. Researchers want t…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Freeze one tumor to supercharge cancer treatment?
Disease control OngoingThis study is testing if adding a freezing treatment called cryoablation to standard immunotherapy helps patients whose cancer has spread. Researchers will freeze one tumor to see if it helps the body's immune system better attack other cancer spots. The trial includes 15 patient…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Early trial tests new drug mixes for Tough-to-Treat cancers
Disease control OngoingThis early-stage trial aims to find safe doses and understand side effects of several drug combinations for patients with advanced cancers that haven't responded to standard treatments. The study involves 155 participants with various advanced or metastatic cancers and some rare …
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Targeted pill trial offers hope for tough cancers with genetic flaw
Disease control OngoingThis study is testing an oral medication called talazoparib for people with advanced cancers that have spread, returned, or stopped responding to standard treatments. It is specifically for patients whose cancers have certain genetic changes in the BRCA pathway (like BRCA1, BRCA2…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Can a week of steroids and exercise beat debilitating cancer fatigue?
Symptom relief OngoingThis study is testing whether combining physical activity with a short course of the steroid dexamethasone can reduce severe fatigue in people with advanced cancer. It enrolled 90 participants to compare a high-dose steroid week with a low-dose steroid week, both alongside a 4-we…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Apr 02, 2026 00:56 UTC
-
New combo fights debilitating cancer fatigue
Symptom relief OngoingThis study aims to see if a common stimulant medication (methylphenidate) combined with a guided exercise program can reduce severe, cancer-related fatigue. It involves 212 patients with advanced cancer who are receiving a specific type of immunotherapy (anti-PD1) and are struggl…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 31, 2026 12:12 UTC
-
Finding calm at the end: testing drug combos for terminal agitation
Symptom relief OngoingThis study aims to find the best way to calm severe, distressing agitation (delirium) in hospitalized patients with advanced cancer who are receiving comfort-focused care. It compares four different drug strategies for patients whose initial low-dose medication isn't working. The…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
New hope for calming terminal cancer agitation
Symptom relief OngoingThis study is testing different medication strategies to quickly calm severe, distressing agitation (delirium) in hospitalized patients with advanced cancer. It involves 70 patients whose initial low-dose medication hasn't worked. Researchers are comparing three approaches: incre…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC
-
Cancer patients asked: exam room or waiting room?
Knowledge-focused OngoingThis study aims to understand the preferences of advanced cancer patients and their caregivers regarding where they wait during outpatient palliative care visits. Researchers want to know if patients and caregivers prefer to go directly to an exam room or wait in a common waiting…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Cancer's hidden cost: study probes financial ruin for patients
Knowledge-focused OngoingThis study aims to understand how common and severe financial distress is for people with advanced cancer. Researchers are asking 141 patients to complete short surveys about their financial situation, symptoms, and quality of life. The goal is to learn how the high cost of cance…
Matched conditions: METASTATIC MALIGNANT NEOPLASM
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC